Magnetic nanoparticles and nanotubes for biomedical applications

Magnetic nanomaterials, especially nanoparticles and nanotubes, are among the most widely used nanomaterials for biomedical applications, and they are also the most promising nanomaterials for clinical treatments. This paper starts with the fundamentals for nanomedicine and magnetic nanomedicine. After discussing the basic requirements for the biomedical applications, the properties and the biomedical applications of magnetic nanoparticles and nanotubes are discussed. Our results indicate that, with suitable functionalization, iron oxide nanomaterials are non-toxic to biological systems, and they are ideal drug carriers which can be remotely controlled by external magnetic fields. At the final part of this paper, the challenges and our approach for targeted drug delivery with controlled release are discussed.

[1]  J. Z. Hilt,et al.  Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Ralph Skomski,et al.  Magnetic nanotubes produced by hydrogen reduction , 2004 .

[3]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[4]  Israel S. Jacobs,et al.  Magnetic Granulometry and Super‐Paramagnetism , 1956 .

[5]  J. Rosenecker,et al.  The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery , 2003, Biological chemistry.

[6]  Daihua Zhang,et al.  Single Crystalline Magnetite Nanotubes. , 2005 .

[7]  Dean-Mo Liu,et al.  Core/Single‐Crystal‐Shell Nanospheres for Controlled Drug Release via a Magnetically Triggered Rupturing Mechanism , 2008, Advanced materials.

[8]  Linfeng Chen,et al.  The effects of functional magnetic nanotubes with incorporated nerve growth factor in neuronal differentiation of PC12 cells , 2008, Nanotechnology.

[9]  Sang Bok Lee,et al.  Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery. , 2005, Journal of the American Chemical Society.

[10]  I. Chen,et al.  Biomedical nanoparticle carriers with combined thermal and magnetic responses , 2009 .

[11]  Christian Bergemann,et al.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.

[12]  R. Stephenson.  A and V , 1962, The British journal of ophthalmology.

[13]  J. Connolly,et al.  Proposed biosensors based on time-dependent properties of magnetic fluids , 2001 .

[14]  J. Bacri,et al.  Biomedical applications of maghemite ferrofluid. , 1998, Biochimie.

[15]  P Wust,et al.  Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  Robert A. Freitas,et al.  Nanomedicine, Volume Iia: Biocompatibility , 2003 .

[17]  Robert A. Freitas,et al.  Nanomedicine, Volume I: Basic Capabilities , 1999 .

[18]  Martin A. M. Gijs,et al.  Magnetic bead handling on-chip: new opportunities for analytical applications , 2004 .

[19]  W. Brown.  Thermal Fluctuations of a Single‐Domain Particle , 1963 .

[20]  Daihua Zhang,et al.  Single crystalline magnetite nanotubes. , 2005, Journal of the American Chemical Society.